Galanin gene expression is increased in the anterior pituitary gland of the human growth hormone-releasing hormone transgenic mouse.

The peptide galanin is synthesized within and secreted from specific cells of the anterior pituitary gland. Previous studies showed that GH-releasing hormone (GHRH) stimulates galanin release from pituitary cells in vitro. In the present study we used human (h) GHRH transgenic mice to examine the effects of high circulating levels of GHRH on pituitary galanin gene expression in vivo. Moreover, the hGHRH transgenic mice develop pituitary tumors and, thus, may be used as a model of estrogen-independent pituitary adenoma formation. We examined male hGHRH transgenic mice and nontransgenic siblings at 2, 4, 6, 8, and 10 months of age. Transgenic mice were identified using the polymerase chain reaction. Body weights and plasma mGH levels were higher in transgenic mice at all ages. Total protein contents in the anterior pituitary glands of transgenic mice were significantly greater at each age. Galanin peptide contents in the anterior pituitary gland of hGHRH mice were normalized for differences in total protein content and were significantly elevated at all ages examined. At 10 months of age, anterior pituitary galanin peptide concentrations were increased 7-fold. Hypothalamic concentrations of galanin peptide were also increased in hGHRH transgenic mice, but were not greater than those in nontransgenic siblings until 4 months of age. In contrast, no significant differences in galanin peptide concentrations of the neurointermediate lobes were evident. Galanin mRNA concentrations in the anterior pituitary of 6-month-old transgenic mice were increased 4-fold. In conclusion, 1) galanin peptide concentrations in the anterior pituitary gland and hypothalamus are increased in hGHRH transgenic mice compared to those in nontransgenic siblings, whereas galanin peptide concentrations in the neurointermediate lobe are not different; 2) pituitary galanin mRNA concentrations are increased 4-fold in 6-month-old transgenic mice; and 3) the development of pituitary hyperplasia is correlated to the increase in galanin mRNA and peptide concentrations.

[1]  J. Moore,et al.  MtTW-10 pituitary tumor cells: galanin gene expression and peptide secretion. , 1993, Endocrinology.

[2]  S. Bloom,et al.  Galanin regulates basal and oestrogen-stimulated lactotroph function , 1993, Nature.

[3]  J. Hyde,et al.  Regulation of galanin gene expression in the rat anterior pituitary gland by the somatostatin analog SMS 201-995. , 1992, Endocrinology.

[4]  E. Rozengurt,et al.  Galanin stimulates Ca2+ mobilization, inositol phosphate accumulation, and clonal growth in small cell lung cancer cells. , 1991, Cancer research.

[5]  J. Hyde,et al.  Galanin secretion from anterior pituitary cells in vitro is regulated by dopamine, somatostatin, and thyrotropin-releasing hormone. , 1991, Endocrinology.

[6]  S. Asa,et al.  Adenohypophysial changes in mice transgenic for human growth hormone-releasing factor: a histological, immunocytochemical, and electron microscopic investigation. , 1989, Endocrinology.

[7]  H. Imura,et al.  Possible mechanisms involved in growth hormone secretion induced by galanin in the rat. , 1989, Endocrinology.

[8]  G. Snyder,et al.  Regulatory role of galanin in control of hypothalamic-anterior pituitary function. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. B. Martin,et al.  Galanin is an estrogen-inducible, secretory product of the rat anterior pituitary. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. Hammer,et al.  Dramatic pituitary hyperplasia in transgenic mice expressing a human growth hormone-releasing factor gene. , 1988, Molecular endocrinology.

[11]  H. Friesen,et al.  Isolation and characterization of a complementary DNA (galanin) clone from estrogen-induced pituitary tumor messenger RNA. , 1987, The Journal of biological chemistry.

[12]  T. Hökfelt,et al.  Evidence for an inhibitory effect of the peptide galanin on dopamine release from the rat median eminence , 1987, Neuroscience Letters.

[13]  D. Jacobowitz,et al.  Quantitative distribution of galanin-like immunoreactivity in the rat central nervous system , 1986, Peptides.

[14]  P. Greengard,et al.  The hypothalamic arcuate nucleus-median eminence complex: Immunohistochemistry of transmitters, peptides and DARPP-32 with special reference to coexistence in dopamine neurons , 1986, Brain Research Reviews.